Home / Topics / cancer vaccine

cancer vaccine Podcasts

1 episode about cancer vaccine

ImmunityBio, Inc. Announced Full Year 2025 Earnings on March 3, 2026, Reporting "Full year net product revenue for ANKTIVA was $113 million" artwork

ImmunityBio, Inc. Announced Full Year 2025 Earnings on March 3, 2026, Reporting "Full year net product revenue for ANKTIVA was $113 million"
ImmunityBio Inc. (IBRX)
• 18:00 •Ep 51 •The Earnings Debate •▶ Play on Apple